首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >US Health Care Reform and Transplantation. Part I: Overview and Impact on Access and Reimbursement in the Private Sector
【24h】

US Health Care Reform and Transplantation. Part I: Overview and Impact on Access and Reimbursement in the Private Sector

机译:美国卫生保健改革与移植。第一部分:私营部门的概况及其对获取和报销的影响

获取原文
获取原文并翻译 | 示例
       

摘要

The Health Care Reform (HCR) legislation passed by Congress in 2010 will have significant impact on transplant centers, patients and health care professionals. The Act seeks to expand coverage, limit the growth in health care costs and reform the delivery and insurance systems. In Part I of this two part series, we provide an overview and perspective of changes in private health insurance resulting from HCR. Under the plan, all Americans will be required to purchase coverage through their employer or via an improved individual/small group market. This legislation limits abusive practices such as limitations on preexisting conditions, lifetime and annual coverage limitations and dropping of beneficiaries if they become sick. The legislation will also limit high-cost plans and regulate premium increases. Private sector reforms are likely to benefit our patients by increasing the number of patients with access to transplant services, since the use of 'preexisting' conditions will be eliminated. However without a concomitant increase in the organ supply, longer waiting times and greater use of marginal organs are likely to increase the cost of transplant. Furthermore, transplant providers will receive reduced reimbursement as a result of market consolidation and the growing power of large transplant networks.
机译:国会在2010年通过的《医疗保健改革(HCR)立法》将对移植中心,患者和医疗保健专业人员产生重大影响。该法案旨在扩大保险范围,限制医疗保健费用的增长,并改革医疗和保险体系。在这两个系列的第一部分中,我们提供了由HCR引起的私人健康保险变化的概述和观点。根据该计划,将要求所有美国人通过其雇主或通过改善的个人/小团体市场购买保险。这项立法限制了虐待行为,例如对既往条件的限制,寿命和年度承保范围的限制以及受益人生病时的下落。立法还将限制高成本计划并规范保费增长。私营部门的改革很可能会通过增加获得移植服务的患者数量使我们的患者受益,因为将消除对“现有”条件的使用。但是,如果没有器官供应的同时增加,等待时间的延长和边缘器官的更多使用可能会增加移植成本。此外,由于市场整合和大型移植网络日益强大的功能,移植提供商将获得减少的报销。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号